Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression

Por Bomken, S, Buechler, L, Rehe, K, Ponthan, F, Elder, A, Blair, H, Bacon, CM, Vormoor, J, Heidenreich, O
Publicado em 2012